Xeljanz 5 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FJ5CJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $184,300
Award facts
- Contract value 100% obligated
- $184,299.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $184,299.58 to AmerisourceBergen Drug Corp for Xeljanz 5 mg tablets (60-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle extending through December 2026 that enables the company to distribute a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and supporting organizations including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs through competitively awarded delivery orders with firm fixed pricing. This Xeljanz delivery order exemplifies the company's role in supplying specialty medications and brand-name pharmaceuticals to federal healthcare systems, leveraging its position as a prime vendor under the DLA's pharmaceutical supply framework.
Quick answers
Who was awarded contract SPE2DB25FJ5CJ?
SPE2DB25FJ5CJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FJ5CJ worth?
The government has obligated $184,300 on SPE2DB25FJ5CJ.
Is contract SPE2DB25FJ5CJ an order under another contract?
Yes. SPE2DB25FJ5CJ is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5CJ competed?
The extent of competition for SPE2DB25FJ5CJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award